Semuloparin for improving the survival of patients with locally advanced cancer

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP11305957.0

公开号：

EP2548561A1

申请日:

2011.07.22

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

The invention relates to an ultra-low molecular weight heparin with an average molecular weight of 2000 to 3000 Daltons, an anti-FXa activity of 145 to 180 U/mg and an anti-FIIa activity of less than 5 U/mg, in particular semuloparin, for use as a prophylactic antithrombotic agent in cancer patients receiving chemotherapy for locally advanced solid tumors, wherein said use improves the survival of patients with locally advanced cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/